Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Retinoic acid and arsenic trioxide in the treatment of acute promyelocytic leukemia: current perspectives

1 Mar 2017

Abstract excerpt

Abstract: Acute promyelocytic leukemia (APL) is a distinct subtype of acute myeloid leukemia (AML) with a unique morphological appearance, associated coagulopathy and canonical balanced translocation of genetic material between chromosomes 15 and 17. APL was first described as a distinct subtype of AML in 1957 by Dr Leif Hillestad who recognized the pattern of an acute leukemia associated with fibrinolysis,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Drug-Induced Ocular Toxicity
Share to Retinoids in leukemia and cellular processes

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28352191
DOI: 10.2147/ott.s100513

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 19 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Retinoic acid and arsenic trioxide in the treatment of acute promyelocytic leukemia: current perspectivesPMID 28352191Read ↗

How retinoic acid and arsenic transformed acute promyelocytic leukemia therapySemantic proximity Read ↗

Acute promyelocytic leukemia: from highly fatal to highly curableSemantic proximity Read ↗

Acute Promyelocytic Leukemia: Pathophysiology, Diagnosis and Clinical ManagementSemantic proximity Read ↗

Acute promyelocytic leukemia (APL): a review of the literatureSemantic proximity Read ↗

Synergistic targeted therapy for acute promyelocytic leukaemia: a model of translational research in human cancerSemantic proximity Read ↗

Treatment of acute promyelocytic leukaemia with <i>all-trans</i> retinoic acid and arsenic trioxide: a paradigm of synergistic molecular targeting therapySemantic proximity Read ↗

Recent advances in acute promyelocytic leukaemiaSemantic proximity Read ↗

Acute Promyelocytic Leukemia: Update on the Mechanisms of Leukemogenesis, Resistance and on Innovative Treatment StrategiesSemantic proximity Read ↗

The Impact of All-trans-Retinoic Acid on the Coagulopathy of Acute Promyelocytic LeukemiaSemantic proximity Read ↗

Acute Promyelocytic Leukemia: Update on the Mechanisms of Leukemogenesis, Resistance and on Innovative Treatment StrategiesSemantic proximity Read ↗

Atypical Rearrangements in APL-Like Acute Myeloid Leukemias: Molecular Characterization and PrognosisSemantic proximity Read ↗

Treatment of Acute Promyelocytic LeukemiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.